Clinical trials: Bipolar Disorder in Remission

Bipolar Disorder

An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder

• Completed
• Age: 18 years and older
• Phase 4
• Results posted

The precursor study (SCA101469) was an open-label, prospective multicentre study in adult subjects diagnosed with bipolar disorder consisting of 36 weeks treatment with lamotrigine.

Trial name

NCT00360126

Testing

lamotrigine

Where

3 sites in Australia

Volunteers

11 people

Sponsor

GlaxoSmithKline